269 related articles for article (PubMed ID: 31211303)
1. Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer.
Palanisamy S; Wang YM
Dalton Trans; 2019 Jul; 48(26):9490-9515. PubMed ID: 31211303
[TBL] [Abstract][Full Text] [Related]
2. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
Mahmoudi M; Sant S; Wang B; Laurent S; Sen T
Adv Drug Deliv Rev; 2011; 63(1-2):24-46. PubMed ID: 20685224
[TBL] [Abstract][Full Text] [Related]
3. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
6. SPIONs for cell labelling and tracking using MRI: magnetite or maghemite?
Barrow M; Taylor A; Fuentes-Caparrós AM; Sharkey J; Daniels LM; Mandal P; Park BK; Murray P; Rosseinsky MJ; Adams DJ
Biomater Sci; 2017 Dec; 6(1):101-106. PubMed ID: 29188240
[TBL] [Abstract][Full Text] [Related]
7. Engineering graphene oxide with ultrasmall SPIONs and smart drug release for cancer theranostics.
Luo Y; Tang Y; Liu T; Chen Q; Zhou X; Wang N; Ma M; Cheng Y; Chen H
Chem Commun (Camb); 2019 Feb; 55(13):1963-1966. PubMed ID: 30681672
[TBL] [Abstract][Full Text] [Related]
8. Current Status of Magnetite-Based Core@Shell Structures for Diagnosis and Therapy in Oncology Short running title: Biomedical Applications of Magnetite@Shell Structures.
Andrade AL; Fabris JD; Domingues RZ; Pereira MC
Curr Pharm Des; 2015; 21(37):5417-33. PubMed ID: 26377654
[TBL] [Abstract][Full Text] [Related]
9. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in the synthesis, properties, and biomedical applications of core/shell superparamagnetic iron oxide nanoparticles with gold.
Sabale S; Kandesar P; Jadhav V; Komorek R; Motkuri RK; Yu XY
Biomater Sci; 2017 Oct; 5(11):2212-2225. PubMed ID: 28901350
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
Santhosh PB; Ulrih NP
Cancer Lett; 2013 Aug; 336(1):8-17. PubMed ID: 23664890
[TBL] [Abstract][Full Text] [Related]
12. Bioevaluation of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with dihexadecyl phosphate (DHP).
Mieloch AA; Żurawek M; Giersig M; Rozwadowska N; Rybka JD
Sci Rep; 2020 Feb; 10(1):2725. PubMed ID: 32066785
[TBL] [Abstract][Full Text] [Related]
13. Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues.
Vakili-Ghartavol R; Momtazi-Borojeni AA; Vakili-Ghartavol Z; Aiyelabegan HT; Jaafari MR; Rezayat SM; Arbabi Bidgoli S
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):443-451. PubMed ID: 32024389
[TBL] [Abstract][Full Text] [Related]
14. Complex of TNF-α and Modified Fe
Teo P; Wang X; Chen B; Zhang H; Yang X; Huang Y; Tang J
Cancer Biother Radiopharm; 2017 Dec; 32(10):379-386. PubMed ID: 29265918
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and in vitro evaluation of exquisite targeting SPIONs-PEG-HER in HER2+ human breast cancer cells.
Almaki JH; Nasiri R; Idris A; Majid FA; Salouti M; Wong TS; Dabagh S; Marvibaigi M; Amini N
Nanotechnology; 2016 Mar; 27(10):105601. PubMed ID: 26861770
[TBL] [Abstract][Full Text] [Related]
16. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
Wahajuddin ; Arora S
Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
[TBL] [Abstract][Full Text] [Related]
17. LyP-1-conjugated Fe
Teo P; Wang X; Zhang J; Zhang H; Yang X; Huang Y; Tang J
J Biomater Sci Polym Ed; 2018 Feb; 29(2):181-194. PubMed ID: 29165044
[TBL] [Abstract][Full Text] [Related]
18. Magnetic nanoparticle-based drug delivery for cancer therapy.
Tietze R; Zaloga J; Unterweger H; Lyer S; Friedrich RP; Janko C; Pöttler M; Dürr S; Alexiou C
Biochem Biophys Res Commun; 2015 Dec; 468(3):463-70. PubMed ID: 26271592
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M
Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Superparamagnetic Iron Oxide Based Nanoprobes as Multifunctional Theranostic Agents for Breast Cancer Imaging and Therapy.
Zheng J; Ren W; Chen T; Jin Y; Li A; Yan K; Wu Y; Wu A
Curr Med Chem; 2018; 25(25):3001-3016. PubMed ID: 28685676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]